These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 706517)

  • 1. [Fibrinogen and fibrin structure in patients with cirrhosis of the liver (author's transl)].
    Klingemann HG; Brunswig D; Liehr H
    Z Gastroenterol; 1978 Sep; 16(9):564-73. PubMed ID: 706517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Blood coagulation disorders in liver cirrhosis in relation to the degree of portal hypertension].
    Klingemann HG; Schmidt U; Brunswig D; Egbring R; Kaffarnik H
    Fortschr Med; 1980 Oct; 98(40):1561-66. PubMed ID: 6970156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
    Brown CH; Crowe MF
    J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.
    Stein SF; Harker LA
    J Lab Clin Med; 1982 Feb; 99(2):217-30. PubMed ID: 7061918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
    Tacke F; Fiedler K; von Depka M; Luedde T; Hecker H; Manns MP; Ganser A; Trautwein C
    Liver Int; 2006 Mar; 26(2):173-81. PubMed ID: 16448455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of fibrin-stabilizing factor on the subunit structure of human fibrin.
    Schwartz ML; Pizzo SV; Hill RL; McKee PA
    J Clin Invest; 1971 Jul; 50(7):1506-13. PubMed ID: 5090065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrin stabilizing factor (factor XIII) activity in liver cirrhosis.
    Yavuzgil C; Karaca M; Göksel V
    New Istanbul Contrib Clin Sci; 1967; 9(2):35-41. PubMed ID: 16300146
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients.
    Cioni G; Cristani A; Mussini C; Grandi S; Pentore R; Zeneroli ML; Tizzanini W; Zagni G; Ventura E
    Ital J Gastroenterol; 1990 Apr; 22(2):70-4. PubMed ID: 2131934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin stabilization, factor XIII transamidase activity and subunits "A" and "B" concentration in plasma of patients with liver cirrhosis.
    Kłoczko J; Wereszczyńska U; Wojtukiewicz M; Gybryelewicz A; Bielawiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):539-44. PubMed ID: 2431976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
    J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alterations of hemostasis in liver cirrhosis of the dog].
    Mischke R; Pöhle D; Schoon HA; Fehr M; Nolte I
    Dtsch Tierarztl Wochenschr; 1998 Feb; 105(2):43-7. PubMed ID: 9528205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ; Marder VJ
    J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet aggregation in portal cirrhosis.
    Ballard HS; Marcus AJ
    Arch Intern Med; 1976 Mar; 136(3):316-9. PubMed ID: 4041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of fibrin and fibrinmonomer in renal and hepatic failure.
    Klingemann HG; Egbring R; Havemann K
    Klin Wochenschr; 1980 May; 58(10):533-5. PubMed ID: 7392532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A microtiter plate assay for factor XIII A-chain-fibrin interactions.
    Achyuthan KE; Santiago MA; Greenberg CS
    Anal Biochem; 1994 May; 219(1):43-8. PubMed ID: 8059954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Decomposition products of fibrin(ogen) and collateral circulation in liver cirrhosis].
    Bungert HJ; Leonhardt H
    Z Gastroenterol; 1973 Apr; 11(3):187-94. PubMed ID: 4803419
    [No Abstract]   [Full Text] [Related]  

  • 18. [Detection of factor XIII deficiency in acute leukemia with resonance thrombography].
    Anders O; Görss EW; Ernst B; Konrad H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):670-9. PubMed ID: 2448208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin and fibrinogen proteolysis products: comparison between gel filtration and SDS polyacrylamide electrophoresis analysis.
    Alkjaersig N; Davies A; Fletcher A
    Thromb Haemost; 1977 Aug; 38(2):524-5. PubMed ID: 145666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostasis activation during esophageal variceal sclerotherapy with thrombin in cirrhotics.
    Fujii Y; Sugawa C; Ozawa T; Nakumura R; Brown-Castillo J; Mammen EF
    Am Surg; 1991 Apr; 57(4):222-5. PubMed ID: 1711300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.